Fourier and Odyssey trials

Study / Research

Large cardiovascular outcome trials for PCSK9 inhibitors, initially doubted by Peter Attia for their ability to show difference given low baseline LDL, but proved successful.

Mentioned in 1 video

Videos Mentioning Fourier and Odyssey trials

255-Latest therapeutics in CVD, APOE’s role in Alzheimer’s disease, familial hypercholesterolemia

255-Latest therapeutics in CVD, APOE’s role in Alzheimer’s disease, familial hypercholesterolemia

Peter Attia MD

Large cardiovascular outcome trials for PCSK9 inhibitors, initially doubted by Peter Attia for their ability to show difference given low baseline LDL, but proved successful.